Post-earnings recap
Reported
Thu, Oct 18, 2018
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report showed Novartis' EPS at $1.32, but without revenue figures or guidance, investors may feel uncertain about future performance. The stock rose by 1.13%, likely reflecting a positive sentiment towards the company's ongoing projects and pipeline. However, the lack of detailed financial metrics may leave some investors cautious.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.32 | N/A | N/A |
Management emphasized their commitment to innovation and maintaining a strong pipeline. There were no specific updates on revenue or future guidance.
Management did not provide specific revenue figures or guidance during the call.
The focus remains on ongoing projects and pipeline developments.